Rationale: The regulation of calcium (Ca
-handling proteins. 2 Phosphorylation of cTnI and PLN promotes relaxation of cardiomyocytes by accelerating Ca 2+ dissociation from cTnC and Ca 2+ reuptake into the SR by SERCA2a, respectively. 3 Combined, activated βAR induces positive inotropic and lusitropic effects. In contrast, chronic βAR activation and sustained increase of intracellular Ca 2+ induces left ventricular (LV) hypertrophy and dysfunction, 4 which ultimately leads to the development of heart failure.
βAR stimulation activates nitric oxide (NO) synthases 1 (NOS1) and NOS3 to produce NO, which regulates cardiac function. 5, 6 For example, NOS1-derived NO S-nitrosylates and activates the ryanodine receptor, resulting in cytosolic Ca 2+ release and enhanced catecholamine-stimulated contractility. 7 On the other hand, NOS3-derived NO increases LV compliance and attenuates βAR-induced inotropy, 5 presumably by activation of soluble guanylate cyclase and subsequent production of cyclic guanosine monophosphate. The existence of multiple downstream signaling mechanisms and different sources of NO has lead to conflicting data regarding the specific contribution of NO and its effectors to the regulation of myocardial function. 8 Accumulating evidence suggests that protein S-nitrosylation (SNO) is a major effector of NO signaling. By analogy to the role of phosphatases, which regulate the levels of protein phosphorylation, amounts of SNO are set by enzymes that metabolize S-nitrosothiols (denitrosylases). Reduction of S-nitrosoglutathione (GSNO) by S-nitrosoglutathione reductase (GSNOR) controls the intracellular levels of protein SNO because GSNO and protein S-nitrosothiols are in equilibrium. 9 Recent studies suggest that signaling through the βAR is regulated by GSNOR-dependent denitrosylation. 10 Nonetheless, the impact of protein SNO on cardiomyocyte function and its regulation by adrenergic signaling is incompletely understood. 
Methods

Animal Studies
The generation of mice deficient in GSNOR (GSNOR −/− ) and PLN (PLN −/− ), as well as mice with cardiomyocyte-specific GSNOR overexpression (GSNOR-Tg), has been described elsewhere. [11] [12] [13] All protocols and experimental procedures were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care and performed in accordance with the guidelines of the National Institutes of Health for the use of animals in research.
Isolated Cardiomyocytes and Langendorff-Perfused Hearts
Isolation of ventricular cardiomyocytes of adult mice and high-speed imaging of Δ [Ca 2+ ] and sarcomere length (SL) shortening (ie, twitch contraction) was performed as previously described with minor modifications. 14, 15 Myocardial Ca 2+ responsiveness was examined in intact cardiomyocytes, as estimated by the ratio of percent SL shortening/Δ [Ca 2+ ], as well as in permeabilized cardiomyocytes. 15 The LTCC current (I Ca,L ) was measured in isolated cardiomyocytes using the whole-cell voltageclamp technique, as previously described. 16 SR Ca 2+ load, SR Ca 2+ leak, and sodium-calcium exchanger (NCX) activity were measured as previously described. 15 All experiments in isolated cardiomyocytes were conducted at 37°C, unless otherwise specified. LV contractility was measured in isolated perfused mouse hearts as described previously.
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In Vivo Chronic βAR Stimulation dl-Isoproterenol (ISO) was administered to mice for 14 days using surgically implanted mini-osmotic pumps (Alzet-20; Durect Corporation, CA). Based on pilot studies, we used a high dose of ISO (60 mg/kg/d) to examine the impact of GSNOR overexpression and a low dose of ISO (30 mg/kg/d) to examine the effects of GSNOR deficiency. After removal of the pumps, mice were observed for an additional 14 days. In vivo cardiac function was evaluated by transthoracic echocardiography, as described previously. 15 At the end of the study, hearts were harvested for histological examination and analysis of protein expression.
Analysis of Protein SNO
A modified biotin switch assay was performed as previously described 18 with minor modifications. Detailed experimental protocols of organic mercury resin-assisted capture of S-nitrosylated proteins and peptides have been published elsewhere. 19 After purification, specific nitrosylated proteins were detected using standard immunoblot techniques.
Adenovirus Specifying Mutant PLN and cTnC
Adenoviral (Ad) constructs were generated encoding wild-type (WT) PLN (C36/C41/C46), single cysteine-to-alanine PLN mutants (C36A, C41A, C46A, respectively), triple PLN mutant (C36A/C41A/C46A), WT cTnC (C35/C84), single cysteine-to-serine cTnC mutants (C35S, C84S), and double cTnC mutant (C35S/C84S) protein. Ad.PLN solution was injected in vivo into the myocardium at the LV apex, and Ad.cTnC was used to infect cultured adult mouse cardiomyocytes.
Statistics
All data are presented as mean±SEM. For isolated cardiomyocyte experiments, measurements of all cells from 1 mouse were averaged, and the average value for each mouse was used for statistical comparison between groups unless otherwise specified. Statistical differences among groups were evaluated using the appropriate statistical tests as indicated in the text.
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Results
GSNOR Modulates Ca 2+ Handling in Cardiomyocytes
After stimulation with the βAR agonist ISO, twitch contraction was increased to the same extent in WT and GSNORTg cardiomyocytes ( Figure 1A ], despite a sustained contractile response to ISO stimulation ( Figure 1B) . In isolated perfused hearts, ISO enhanced LV inotropy in both GSNORTg and WT hearts (Online Figure IC) ] in GSNOR-Tg hearts during βAR stimulation ( Figure 1C ). The NO scavenger carboxy-PTIO (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide potassium salt) also prevented the ISO-induced increase in Δ[Ca
2+
] in WT cardiomyocytes without affecting inotropy ( Figure 1D ). These observations suggest that SNO mediates both an augmentation of Δ[Ca
] and a decrease in myocardial sensitivity to Ca 2+ during βAR stimulation.
Enhanced Denitrosylation Prevents LV Hypertrophy and Dysfunction During Chronic βAR Stimulation
] activates calcineurin, leading to the translocation of nuclear factor of activated T-cells and the activation of downstream hypertrophic signaling. Because GSNOR-Tg inhibited ISO-induced increases in both Δ[Ca
2+
] and calcineurin activity ( Figure 1B and 1C) , we surmised that denitrosylation may mitigate LV remodeling in response to adrenergic stimulation. Infusion of ISO (60 mg/kg/d) in WT mice for 2 weeks resulted in marked LV and cardiomyocyte hypertrophy and myocardial fibrosis, associated with the nuclear translocation of nuclear factor of activated T-cells-c3 ( Figure 2 ). GSNOR-Tg prevented ISO-induced translocation of nuclear factor of activated T-cells-c3 and the associated LV remodeling and dysfunction. In contrast, when we challenged WT and GSNOR −/− mice with a lower dose of ISO (30 mg/kg/d), GSNOR deficiency worsened LV remodeling and dysfunction (Online Figure II) . These observations suggest that S-nitrosothiol homeostasis plays an important role in limiting pathological hypertrophy by titrating Δ[Ca
].
GSNOR Overexpression or NOS Inhibition Prevents SNO of Ca
2+ -Handling Proteins After βAR Stimulation
We used both the modified biotin switch assay and phenyl mercury resin-assisted capture method to identify Ca 2+ -handling proteins that undergo SNO after βAR stimulation in lysates of isolated WT and GSNOR-Tg cardiomyocytes incubated with ISO (10 nmol/L). Stimulation by ISO increased the SNO of PLN, NCX, and cTnC, but not ryanodine receptor, SERCA2a, LTCC, cTnI, tropomyosin, or actin, in WT cardiomyocytes, as detected by modified biotin switch ( Figure 3 ; Online Figure III ). GSNOR-Tg or inhibition of NO synthesis with L-NG-nitroarginine-methylester blocked ISO-induced SNO of PLN, NCX, and cTnC ( Figure 3 ). In contrast, we found that all Ca 2+ -handling proteins probed were S-nitrosylated in ISO-treated WT, but not in GSNORTg, cardiomyocytes, as determined by mercury resin-assisted capture (Online Figure IV) . Thus, βAR stimulation induces GSNOR-coupled, reversible SNO of multiple Ca 2+ -handling proteins, including PLN, NCX, and cTnC. 
Phosphorylation of PLN Is Insufficient for βAR-
Induced PLN Pentamerization
The amount of Ca 2+ released into the cytosol is predominantly determined by the function of LTCC and SR.
2 Because GSNOR-Tg did not affect LTCC current with or without ISO (Online Figure V) , we tested the effect of GSNOR on SR function. βAR stimulation increased SR Ca 2+ load, SR Ca 2+ leak, and fractional Ca 2+ release in a dose-dependent manner in WT, but not in GSNOR-Tg, cardiomyocytes ( Figure 4A ). These results suggest that ISO failed to activate SERCA2a in GSNOR-Tg myocytes. The monomeric form of PLN inhibits SERCA2a, whereas the pentameric form is functionally inactive. 20 Under basal conditions, the PLN pentamer/monomer ratio was similar in WT and GSNOR-Tg hearts ( Figure 4B ). In WT cardiomyocytes, ISO markedly increased the PLN pentamer/monomer ratio, whereas in GSNOR-Tg myocytes or in WT cardiomyocytes treated with carboxy-PTIO, ISO failed to alter the PLN pentamer/monomer ratio ( Figure 4B ). Of note, the levels of ISO-induced PLN phosphorylation at Ser 16 and Thr 17 did not differ between WT and GSNOR-Tg cardiomyocytes ( Figure 4C ), indicating that protein kinase A and Ca 2+ /calmodulin-dependent protein kinase II-mediated phosphorylation of PLN is not altered by GSNOR-Tg and that it is not sufficient to cause pentamerization without concomitant SNO. ), which are located in the hydrophobic C-terminal transmembrane region (Online Figure VIA-VIC) and likely modulate oligomerization of PLN. 21 To elucidate the role of βAR-induced SNO of PLN on Ca 2+ handling, we constructed recombinant adenovirus vectors encoding mutant PLN in which cysteines are replaced by alanines (Online Figure VID and VIE) . In human embryonic kidney 293 cells expressing Ad.PLN, mutation of all cysteines to alanines (C36A/C41A/C46A) abolished SNO of PLN by exogenous S-nitrosocysteine, a cell-permeable S-nitrosothiol (Online Figure VIF) . Moreover, in human umbilical vein endothelial cells (with intact βAR) expressing Ad.PLN, ISO nitosylated WT PLN, but not mutant PLN C36A/C41A/C46A (Online Figure VIG) . We examined the effects of expressing SNO-resistant PLN mutants on Ca ] decay and SL relengthening at baseline or after βAR stimulation (Online Figure VIIA and VIIB) . This suggests that an alternative mechanism of Ca 2+ removal compensates for the lack of SERCA2a activity in GSNORTg cardiomyocytes treated with ISO. We found that ISO dose-dependently increased NCX activity in GSNOR-Tg, but , an important regulator of Ca 2+ sensitivity, was increased to a similar extent by ISO in WT and GSNOR-Tg hearts ( Figure 6B ). These results suggest that protein SNO is required for the ability of ISO to reduce myfilament Ca 2+ sensitivity.
SNO of PLN at
Enhanced Denitrosylation Augments the Temperature-Dependent Increase of Myocardial Ca 2+ Responsiveness
To define the mechanisms responsible for the increased myocardial Ca 2+ sensitivity in ISO-treated GSNOR-Tg cardiomyocytes, we examined the impact of temperature on myocardial Ca 2+ responsiveness with or without ISO, as assessed by the ratio of percent SL shortening/Δ [Ca 2+ ], during twitch contraction in intact cardiomyocytes. Myocardial Ca 2+ responsiveness was similar at 37°C and 25°C in WT cardiomyocytes with or without ISO, although there was a trend toward lower Ca 2+ responsiveness with ISO at both temperatures (Table) . Increase of temperature from 25°C to 37°C markedly increased Ca 2+ responsiveness in GSNOR-Tg cardiomyocytes (Table) . ISO increased Ca 2+ responsiveness at 37°C, but not at 25°C, in GSNOR-Tg cardiomyocytes. Because increase in Ca 2+ responsiveness with temperature is largely determined by the temperature dependence of cross-bridge cycling rates, 23 these results suggest that enhanced denitrosylation increases myocardial Ca 2+ responsiveness during βAR stimulation by accelerating cross-bridge cycling at physiological temperature. 
Discussion
The current observations uncover the existence of previously unrecognized signaling events dependent on SNO of key Ca 2+ -handling proteins during βAR stimulation. Although multiple Ca 2+ -handling SNO proteins, including PLN, have been previously reported, 24 our findings reveal a far more important role for SNO in transduction of adrenergic activation and hypertrophic signaling than previously thought. Phosphorylation and SNO in fact work in concert to control Ca 2+ homeostasis ( Figure 7) .
As is the case for phosphorylation, SNO is pervasive. Therefore, many proteins are potential targets for both SNO and phosphorylation. 25 Using 2 distinct enrichment techniques for S-nitrosylated proteins, we found that many, if not all, cardiac Ca 2+ -handling proteins can be S-nitrosylated by βAR stimulation. Although different sets of S-nitrosylated proteins were detected by modified biotin switch and mercury resinassisted capture (reflecting the differences in reactivities of assay reactants, ie, ascorbate versus organic mercury, respectively), ISO-induced SNO of Ca 2+ -handling proteins was completely inhibited by GSNOR-Tg, establishing the specificity of both techniques. Furthermore, 3 Ca 2+ -handling proteins (ie, PLN, NCX, and cTnC) were found to be S-nitrosylated in WT cardiomyocytes after βAR stimulation by both methods, suggesting the robustness of these SNO proteins. Consistent with this, SNO-resistant Cys mutants in PLN and cTnC recapitulate the phenotype of GSNOR-Tg cardiomyocytes (ie, impairment of ISO-induced increase of Δ[Ca
2+
] and ISO-induced enhancement of Ca 2+ sensitivity, respectively). Our data suggest that SNO of PLN and cTnC is critically important for the transduction of βAR signaling in cardiomyocytes.
The central role of PLN in myocardial Ca 2+ handling has been established by studies using PLN −/− mice. 26 Previous studies using a nonphosphorylatable mutant of PLN showed that phosphorylation of PLN at Ser 16 is necessary for mediating the maximal myocardial response to βAR stimulation. 3, 22 However, the SNO status of PLN SNO was not addressed in that study. The current results show that βAR stimulation induces both phosphorylation and SNO of PLN. Moreover, when SNO of PLN was prevented by GSNORTg or NO scavenging, βAR stimulation failed to induce PLN pentamerization and SERCA2a activation, despite intact phosphorylation of PLN. These results indicate that phosphorylation is necessary but not sufficient for PLN pentamerization and activation of SERCA2a during βAR stimulation. It has been postulated that cysteine residues in the transmembrane domain of PLN play a role in pentamer formation and stability. 27 Whether SNO-PLN leads to disulfide bond formation between PLN monomers remains to be determined. 28 βAR stimulation exerts inotropic effects as a net consequence of increased Δ[Ca 2+ ], reduced thin filament Ca 2+ sensitivity, and enhanced cross-bridge cycling ( Figure 7 ). Although the relative contribution of these 3 components to βAR-induced inotropy is still debated, mathematical modeling suggests that enhanced cross-bridge cycling plays a central role in the βAR-induced twitch responses. 29 Without it, the Δ[Ca 2+ ] is only able to offset the intrinsic negative inotropic effect of ISO-induced reduction in thin-filament Ca 2+ sensitivity. In the current study, we observed that GSNORTg abolished the ability of ISO to increase Δ[Ca 2+ ] without impairing inotropic twitch responses. Similarly, cTnC C84S mutation further augmented ISO-induced inotropy without augmenting Δ[Ca 2+ ]. These observations suggest that GSNOR-Tg and cTnC C84S either prevented the reduction of thin filament Ca 2+ sensitivity or augmented the cross-bridge cycling in response to ISO.
βAR signaling is transduced through the cTnI N-terminus (residues 1-30), which is thought to be bound to the N-domain of cTnC when unphosphorylated and to dissociate on phosphorylation at Ser 23/24 . 30 The dissociation of cTnI N-terminus decreases the affinity of the cTnI switch region (residues 147-163) to the N-domain of cTnC, thus decreasing the Ca 2+ sensitivity of thin filaments. 31 The crystal structure of cTnC shows that Cys 84 is located in the hydrophobic core at the D-helix of the N-domain that interacts with the switch region of cTnI (Online Figure IXC) . 31, 32 It has been reported that Cys 84 contributes to the formation of intramolecular (within cTnC) or intermolecular (between cTnC and cTnI) disulfide bonds, which may affect the cTnI-cTnC interaction. 33 These data support the idea that βAR-induced nitrosylation of cTnC at Cys 84 may regulate cTnI-cTnC interactions, thereby influencing myofilament Ca 2+ sensitivity. Indeed, a missense mutation of cTnC (cTnC C84Y ) has been found to be associated with hypertrophic cardiomyopathy and to increase the Ca 2+ sensitivity of reconstituted skinned fibers, indicating an important role of Cys 84 in modulating Ca 2+ sensitivity. Alternatively, SNO may alter myocardial Ca 2+ sensitivity by modulating cross-bridge cycling kinetics. It is known that physiological temperature (eg, 37°C) increases myocardial Ca 2+ responsiveness primarily because of increased cross-bridge cycling rates compared with lower temperatures (eg, 15-25°C). 23, 35 We observed that the temperature-dependent increase of Ca 2+ responsiveness was markedly exaggerated in ISO-treated GSNOR-Tg cardiomyocytes. These results suggest that ISO-induced twitch inotropy in GSNOR-Tg cardiomyocytes is at least partly mediated by enhanced cross-bridge cycling. This hypothesis is consistent with a previous report that NO reduces myocardial Ca 2+ sensitivity by slowing cross-bridge cycling rates. 36 The temperature dependency of the effects of SNO-myofilament proteins also explains why the effects of SNO to reduce myofilament Ca 2+ sensitivity were not observed in most previous studies where myofilament Ca 2+ sensitivity was typically measured only at or below room temperature (eg, 15°C). 37 In addition to its well-documented role in myocardial contractile function, Ca 2+ plays an important role in programming myocardial hypertrophy, including the calcineurin-nuclear factor of activated T-cells signaling. 2, 38 Because GSNOR-Tg attenuated ISO-induced increases in Δ[Ca 2+ ], hypertrophic signaling, and LV dysfunction, whereas GSNOR −/− worsened LV remodeling after chronic ISO infusion, we suggest that protein denitrosylation protects against pathological LV remodeling and heart failure in response to whereas GSNOR-Tg prevented sepsis-induced LV dysfunction in mice.
13 Consistent with our current results, βAR-induced hyper-SNO of ryanodine receptor was shown to increase SR Ca 2+ leak and depress the myocardial response to βAR stimulation in GSNOR −/− mice. 9 On the other hand, GSNOR deficiency prevented oxidative stress-induced increase in SR Ca 2+ leak 39 and reduced myocardial injury after permanent left coronary artery ligation. 40 Although the current study showed that enhanced denitrosylation has protective effects against LV remodeling in response to chronic βAR stimulation, the effects of GSNOR on the development of LV dysfunction remain to be determined in more clinically relevant models of heart failure.
It has been reported that NOS1 deficiency depresses SERCA2a function at baseline and blunts positive inotropic response to βAR stimulation. 41, 42 Because NOS1 is localized to the SR, PLN SNO is likely impaired in NOS1 −/− cardiomyocytes, in line with our results in GSNOR-Tg mice in which ISO failed to activate SERCA2a and nitrosylate PLN. Nonetheless, the phenotype of GSNOR-Tg cardiomyocytes is unlikely to be the same as that of NOS1 −/− or NOS1/NOS3 double knockout mice. 8 GSNOR only denitrosylates a subset of the nitrosoproteome, 43 whereas SNO depletion may be more complete in NOS1/NOS3 double knockout cardiomyocytes. In fact, we observed no difference in the SNO levels of Ca
-handling proteins at baseline between WT and GSNOR-Tg cardiomyocytes. In addition, deficiency of NOS abolishes both cyclic guanosine monophosphate-dependent and -independent effects (ie, SNO) of NO, whereas GSNOR-Tg attenuates protein SNO and leaves cyclic guanosine monophosphate-dependent effects intact. 13 These differences may explain the discrepancies in Ca 2+ -handling parameters obtained in our current studies in GSNOR-Tg mice and previous studies using NOS-deficient mice.
Calcium is the primary determinant of cardiac force production. Alterations in phosphorylation levels of Ca 2+ -handling proteins downstream of the βAR not only control myocardial contraction and relaxation but also represent molecular signatures of failing hearts. Our observations reveal previously unrecognized roles for SNO of Ca 2+ -handling proteins, particularly PLN and cTnC, in transducing adrenergic and hypertrophic responses of the heart. S-Nitrosylation may thus operate in parallel with protein phosphorylation to exert widespread control over cardiac function, and both may go awry in disease. 44 Denitrosylation-based approaches may represent a new therapeutic strategy to improve cardiac function in settings of increased nitrosative stress, including heart failure, 45 myocardial ischemia, 46 and sepsis. ) homeostasis by β-adrenergic receptor (βAR) activation is a fundamental mechanism of sympathetic regulation of myocardial function, as well as a basis for understanding molecular events that result in hypertrophic signaling and heart failure.
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• Sympathetic activation of βAR not only induces protein phosphorylation but also stimulates nitric oxide production.
• Nitric oxide-dependent protein S-nitrosylation modulates myocardial function.
What New Information Does This Article Contribute?
• S-nitrosylation provides an essential parallel pathway that acts in concert with phosphorylation to regulate cardiac Ca 2+ homeostasis.
• βAR stimulation-induced S-nitrosylation of phospholamban is necessary for its pentamerization, which increases Ca 2+ transients, whereas S-nitrosylation of cardiac troponin C (cTnC) is required to decrease myocardial Ca 2+ sensitivity.
• Enhanced denitrosylation prevents pathological left ventricular hypertrophy induced by chronic βAR activation by limiting Ca 2+ overload.
Sympathetic activation critically regulates myocardial function via βAR-dependent signaling. Activation of βAR modulates Ca 2+ handling of cardiac myocytes typically via protein phosphorylation. Although nitric oxide modulates cardiac function by S-nitrosylating proteins, how S-nitrosylation affects βAR signaling was incompletely understood. Using transgenic mice to titrate the levels of protein S-nitrosylation, we uncovered unanticipated roles for protein S-nitrosylation, in general, and of phospholamban and cTnC, in particular, in the βAR-dependent regulation of Ca 2+ homeostasis. Notably, S-nitrosylation of phospholamban consequent upon βAR activation is necessary to augment Ca 2+ release from sarcoplasmic reticulum during contraction. In parallel, S-nitrosylation of cTnC is required to decrease myocardial Ca 2+ sensitivity in response to βAR stimulation. Global inhibition of cellular S-nitrosylation prevents hypertrophic signaling in response to chronic adrenergic stimulation, whereas selective inhibition of cTnC S-nitrosylation recapitulates the impact of naturally occurring mutation (cTnC C84Y ). Thus, S-nitrosylation provides a previously unrecognized parallel pathway, at least in part through phospholamban and cTnC, which acts in concert with phosphorylation to regulate cardiac Ca 2+ homeostasis. Inhibition of S-nitrosylation of specific protein targets may prove to be a therapeutic option for the treatment of heart failure.
SUPPLEMENTAL MATERIAL S-nitrosylation of calcium-handling proteins in cardiac adrenergic signaling and hypertrophy
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DETAILED METHODS
Mice and drugs
All protocols and experimental procedures were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care and performed in accordance with the guidelines of the National Institutes of Health for the use of animals in research. The generation of PLN deficient (PLN -/-) mice, mice with cardiomyocyte-specific GSNOR overexpression (GSNOR-Tg) and GSNOR deficient (GSNOR -/-) mice has been described elsewhere.
1-3 PLN -/-and GSNOR -/-mice were backcrossed on to FVB/N and C57BL6 background, respectively, for more than 10 generations. Wild-type (WT) FVB/N and C57BL6 mice were used as WT controls for PLN -/-and GSNOR -/-mice, respectively. Wild-type littermate mice were used as controls for GSNOR-Tg. Male WT, GSNOR-Tg, and GSNOR -/-mice (2-to 4-months-old) were age-and weight-matched throughout the study. Unless otherwise noted, all chemicals were obtained from Sigma-Aldrich (Saint-Louis, MI).
Cardiomyocyte isolation
Isolation of adult mouse ventricular cardiomyocytes was carried out as previously described with minor modifications. 4, 5 Briefly, the animals were heparinized (8,000 U/kg, i.p.) and deeply anesthetized with an overdose of pentobarbital (300 mg/kg, i.p.). The heart was rapidly excised and the aorta was cannulated. The heart was retrogradely perfused with calcium-free cell isolation buffer ( 
Measurement of contractility and calcium concentration in isolated cardiomyocytes
Cardiomyocytes were loaded with the Ca 2+ -sensitive fluorescent dye Fura-2/acetoxy methylester (Invitrogen, Carlsbad, CA) at a concentration of 1.5 µmol/L in Tyrode buffer for 20 min at 25 °C. Cardiomyocytes were superfused with Tyrode buffer at 37 °C and paced at 2 Hz by a MyoPacer Field Stimulator (IonOptix, Milton, MA), and sarcomere length and Fura-2 fluorescence were recorded simultaneously using a dual-excitation fluorescence photomultiplier system (Hyperswitch Light Source; IonOptix). The ratio of photon live count detected by the excitation at 340 nm compared with 380 nm represents the Fura-2 fluorescence ratio, which is a measure of the intracellular Ca 2+ concentration. Sarcomere length and Δ[Ca 2+ ] data were analyzed with IonWizard software. To assess the acute effects of βAR stimulation, continuous recording was performed. After 30 sec recording of sarcomere shortening and Δ[Ca 2+ ] at baseline, Tyrode buffer was rapidly switched to Tyrode buffer containing DL-isoproterenol (ISO) at 10 nmol/L and measurements were continued until a steady-state was reached. For the dose-response measurements, isolated cardiomyocytes were pretreated with different concentrations of ISO for 10 min before measurement of contractility and Δ[Ca 2+ ]. To assess the effect of scavenging NO, isolated cardiomyocytes were incubated with 300 µmol/L carboxy-PTIO for 10min.
Measurements of LV contractility with isolated perfused mouse hearts
LV contractility was measured in isolated perfused mouse hearts, as described previously. 6 Briefly, after pentobarbital anesthesia (50 mg/kg i.p.), the heart was excised and transferred to ice-cold perfusion buffer (a modified Krebs-Henseleit buffer, containing, in mmol/L: NaCl 118.5; NaHCO 3 25; glucose 11; KCl 4; MgSO 4 1.2; KH 2 PO 4 1.2; pyruvate 1; CaCl 2 1.8; gassed and equilibrated with 95% O 2 and 5% CO 2 at 37°C). The aorta was cannulated and the heart was mounted on the Langendorff apparatus and retrogradely perfused at an initial pressure of 70 mmHg. Coronary flow rate was measured using an N1 in-line flow probe and a T106 flow meter (Transonic Systems, Ithaca, NY) and maintained at a constant rate (2.0-3.5 ml/min). After stabilization, increasing concentrations of ISO (10, 100, 1000 nmol/L) were infused. The LV diastolic pressure was initially set at 5-10 mmHg using a fluid-filled balloon inserted into the LV, which also contained the tip of a Millar SPR-671 pressure transducer (ADInstruments, Colorado Springs, CO). LV pressure was constantly measured, and maximum and minimum rate of LV pressure change (dP/dt max and dP/dt min , respectively) were calculated from the LV pressure signal using a Powerlab 8/30 data acquisition system and Chart Pro software (ADInstruments, Colorado Springs, CO).
Calcineurin activity assay
After perfusion with ISO (1000 nmol/L) during the Langendorff experiments, heart samples were collected. Baseline hearts were perfused with perfusion buffer only. Calcineurin activity was measured by using Calcineurin Cellular Activity Assay Kit (BML-AK816, Enzo life science, Farmingdale, NY) following the manufacture's instructions.
Chronic isoproterenol infusion
ISO (60 mg/kg/day for the comparison between WT and GSNOR-Tg or 30 mg/kg/day for the comparison between WT and GSNOR -/-) was administered to mice for 14 days using miniosmotic pumps (Alzet-20; Durect Corporation, CA). The pumps were implanted in the interscapular region under 2-3% inhaled isoflurane anesthesia. At the end of the treatment period, pumps were surgically removed. After each surgical procedure, cefazolin (100mg/kg i.p.) was administered. Bupivacaine (0.25%, 2 mg/kg infiltration around incision) and Buprenorphine (0.1 mg/kg s.c.) were administered 30 min before the procedure and 12 and 24 hours after to minimize discomfort.
Echocardiography
In vivo cardiac function was evaluated before and 7, 14, and 28 days after implantation of mini-osmotic pumps by transthoracic echocardiography, as described previously. 5 Mice were lightly anesthetized with ketamine (20 mg/kg), and images were collected using a 13.0-MHz linear probe (Vivid 7; GE Medical System, Milwaukee, WI). Interventricular septum thicknesses in diastole (IVSTd) and M-mode images were obtained from a parasternal shortaxis view at the midventricular level with a clear view of the papillary muscle. Left ventricular (LV) internal diameters at end-diastole (LVIDd) and end-systole (LVIDs) and LV posterior wall thickness in diastole (LVPWTd) were measured. The fractional shortening, ejection fraction, heart rate and LV mass were calculated on an EchoPAC workstation (GE Healthcare, Wauwatosa, WI). LV mass was calculated according to the 
Histology
Mice were weighed, and hearts were dissected 28 days after ISO pump implantation. The hearts were perfused first with sterile cold PBS, and weighed. Hearts were fixed in 4% paraformaldehyde in PBS for 24 hours. After fixation, hearts were embedded in paraffin. Sections (4 µm) were prepared at 200 µm intervals. Hematoxylin and eosin staining (HE staining) and Masson's Trichrome staining (MT staining) were performed by standard methods. Cardiomyocyte hypertrophy was assessed by measuring the cross-sectional area of on average 207±12 cardiomyocytes per HE stained section. Cardiac fibrosis was determined by calculating the percentage of MT stained area of interstitial fibrosis per total area of cardiac tissue in 11 randomly selected fields. Histological observations were performed with a fluorescence microscope (Nikon ECLIPSE-TE2000-S). Histological images were analyzed using NIH ImageJ software (version 1.43). Measurements and analysis were performed by an investigator blinded to the identity of the samples.
Protein immunodetection
Hearts dissected 28 days after osmotic mini-pump implantation were homogenized and separated in nuclear and cytoplasmic fractions using a Nuclear Extraction Kit (Active Motif; Carlsbad, CA) according to the manufacturer's protocol. Protein extracts from isolated cardiomyocytes with or without pretreatment with ISO (10 nmol/L) were prepared using lysis buffer containing (in mmol/L): 50 Tris-HCl (pH 7.4), 150 NaCl, 1 EDTA, 0.1 PMSF, 1% NP-40, 0.1 % SDS, 1:100 phosphatase inhibitor cocktail, and 1:100 protease inhibitor cocktail. Samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis with a Mini-Protean System (Bio-Rad, Hercules, CA) and transferred to PVDF membranes. The membranes were blocked in 2% nonfat dry milk in TBS for 1 h and then probed subsequently with primary and secondary antibodies as listed in Online Table I . Horseradish peroxidaselinked secondary antibodies were visualized using chemiluminescence with the ECL Advance kit (GE Healthcare, Piscataway, NJ). Densitometric analysis of the results was carried out with NIH ImageJ software (version 1.43).
Modified biotin switch assay to detect protein S-nitrosylation
Biotin switch assay was performed as previously described 8 with minor modifications. Briefly, isolated cardiomyocytes were homogenized in lysis buffer containing (in mmol/L) 25 HEPES (pH7.4), 50 NaCl, 1 EDTA, 0.2 neocuproine, 1 PMSF, 1 %( v/v) NP-40 and 1:100 protease inhibitor cocktail. Samples were diluted to 0.6 µg/µl with HEN buffer containing (in mmol/L) 250 HEPES (pH 7.4), 1 EDTA and 0.2 neocuproine, and free thiol residues were then blocked by adding 100 mmol/L N-ethylmaleimide and incubated for 30 min at 50°C with frequent vortexing. Next, the protein S-nitrosocysteine were reduced with L-ascorbate (30 mmol/L) and labeled with N-[6-(biotinamido) hexyl]-3′-(2′-pyridyldithio) propionamide (0.2 mmol/L). Biotinylated proteins were then purified using streptavidin-agarose beads. As a positive control, isolated cardiomyocytes were incubated with CysNO (100 µmol/L) for 15 min before homogenization. For negative control samples, L-ascorbate was omitted during the biotin labeling step. Specific proteins were detected in the streptavidin-purified mixture using standard immunoblot techniques as described above.
Mercury resin-assisted capture
Detailed experimental protocols of organic mercury resin-assisted enrichment for Snitrosylated proteins and peptides have been published elsewhere. 9, 10 Briefly, protein suspensions were diluted at 0.5 mg/mL in HEN buffer containing (in mmol/L) 250 Hepes, 1 DTPA, 0.1 neocuproine and 2.5% (v/v) SDS and free thiols were blocked with 35 mM methyl methanethiosulfonate (MMTS) for 30 min at 55°C with frequent vortexing. MMTS-blocked protein suspensions were loaded onto chromatographic columns containing activated phenylmercury resin and left to react for 60min at 25°C. Nonspecific interactions were eliminated with extensive washes and bound proteins were eluted with 50 mM bmercapoethanol. Bound fractions were processed for western blot based identification of the proteins of interest using specific antibodies.
Measurement of L type Ca
2+ current The L-Type Ca 2+ channel (LTCC) current (I Ca,L ) was measured in isolated cardiomyocytes using the whole-cell voltage-clamp technique, as previously described. 11 Depolarizations of 500 ms from -80 mV to various membrane potentials were applied every 4 seconds and were preceded by a 100-ms prepulse to -40 mV to inactivate the Na + current. The external solution was K + -free (to eliminate inward K + currents) and contained (in mmol/L) 140 NaCl, 2 CaCl 2 , 1 MgCl 2 , 5 HEPES and 10 glucose. For selective measurement of I Ca,L , the pipette solution contained (in mmol/L) 110 CsCl, 5 MgATP, 10 HEPES, 0. 2+ released after addition of 10 mmol/L caffeine. Fractional SR calcium release was calculated as the ratio of the twitch calcium transient to the caffeine-stimulated calcium transient. 13 NCX activity was assessed by first superfusing myocytes with Tyrode buffer and measuring the intracellular Ca 2+ transient after addition of 10 mmol/L caffeine, and subsequently repeating this measurement during superfusion with the 0 Na + , 0 Ca 2+ Tyrode buffer to inhibit NCX activity. The difference in the decay rate of the caffeine-induced calcium transient between the two traces was taken to represent NCX activity.
14 All experiments were performed at 37 °C.
Measurement of PLN monomer and pentamer
After excision of the heart from pentobarbital (50 mg/kg i.p.) anesthetized mice, the aorta was cannulated immediately and hearts were perfused retrogradely for 10 min, maintaining a perfusion pressure of 60-80 mmHg with a modified Krebs-Henseleit buffer with or without ISO (10 nmol/L) as described above. After 10 min perfusion, the heart was frozen immediately in liquid nitrogen. Heart samples were homogenized in lysis buffer containing (in mmol/L) 10 Tris (pH 7.5), 315 Sucrose, 1 EDTA, 1 PMSF and 1:100 protease inhibitor cocktail. Protein concentrations were quantified by BCA assay (Pierce Biotechnology). Concentrated (4X) SDS-sample buffer containing (in mmol/L) 8% (w/v) SDS, 600 NaCl, 40% (w/v) glycerol, 0.1% bromophenol blue was added and samples were either kept on ice or boiled for 5 minutes. DTT (62 mmol/L) was added to a portion of the samples that were boiled to reduce any disulfide bonds. PLN monomers and pentamers were then detected using standard immunoblot techniques as described above.
Generation of mutant PLN adenovirus
We used the GeneStrings gene synthesis service (Invitrogen, Carlsbad, CA) to generate DNA encoding wild-type and mutant PLN. We generated DNAs encoding single cysteine-to-alanine mutations at positions 36, 41, and 46 in the PLN protein (C36A, C41A, C46A, respectively), as well as a triple mutant (C36A/C41A/C46A) and a wild-type control (C36/C41/C46). These DNAs were then cloned into the pAdTrace-Tox vector, which was a kind gift of Dr. He (University of Chicago Medical Center). The vector contains a CMV-driven monomeric red fluorescent protein (mRFP1) marker, a CMV-flanked insertion site for the gene of interest, and two regions of sequence homology to a vector carrying the adenoviral backbone.
The plasmids encoding wild-type and mutant PLN were used to transform the AdEasier-1 bacterial strain (Addgene, Cambridge, MA), which contains a plasmid encoding the E1/E3-deficient adenoviral backbone with homology to the pAdTrace-TOX shuttle vector. The AdEasier-1 cells are based on the recBC sbc BJ5183 strain, which allows for homologous recombination of the shuttle vector with the adenoviral backbone, leading to generation of the final adenoviral DNA construct containing the gene of interest. 15 After confirmation of correct recombination, the adenoviral vector was used to transform recombination-defective TOP10 bacteria (Invitrogen) to avoid further unwanted recombination during plasmid amplification. The adenoviral vector was linearized and transfected into the AD-293 cell line (Agilent Technologies, Santa Clara, CA) using Lipofectamine 2000 (Invitrogen). Successful transfection was confirmed by verifying mRFP1 expression of AD-293 cells using fluorescence microscopy. Adenovirus was harvested from these cells and further amplified to reach a titer of ~10
11 -10 12 pfu/ml using procedures described by Luo et al.
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In vivo gene transfer with adenovirus encoding wild-type or mutant PLN Mice were anesthetized with 5 % isoflurane in 100 % oxygen, intubated, ventilated mechanically (Mini-Vent; Harvard Apparatus, Holliston, MA, USA) and maintained with 2.0 % isoflurane in the right lateral decubitus position. Cefazolin (40 mg/kg) was administered intraperitoneally before the surgical procedure. Core body temperature was maintained at 37 ˚C throughout the procedure. A transverse 10-mm incision of the skin was made under the axilla and the chest was opened at the level of 4th intercostal space. A subsequent incision was made into the pericardium to reveal the left ventricular wall. Virus solution was injected into the myocardium at the left ventricular apex in a total volume of 40 to 50 µL. After hemostasis was achieved, the chest and skin were closed with 5-0 monofilament suture, mice were extubated, and returned to their cages. Bupivacaine (0.25%, 2mg/kg) was infiltrated around the incisional wound 2h after surgery before mice were allowed to wake up, and buprenorphine (0.1 mg/kg, i.p.) was administered before and 12h after the procedure to minimize discomfort.
Measurement of Ca 2+ responsiveness in intact cardiomyocytes
Changes in the extracellular Ca 2+ concentration ([Ca 2+ ] ex )-shortening relation were examined in intact cardiomyocytes as previously described 16 . Baseline variables were collected from individual myocytes for 1.5 min. Concentration-response curve measurements were subsequently performed during superfusion with Tyrode buffer containing 0.5, 1, 2 and 4 mmol/L CaCl 2 . Data were then acquired for 1.5 min after establishment of a new steady state.
Measurement of myofilament Ca
2+ sensitivity in permeabilized cardiomyocytes After isolated cardiomyocytes were pretreated with 10 nmol/L DL-isoproterenol (ISO) for 15 min, WT and GSNOR-Tg cardiomyocytes were dissociated and permeabilized according to the method described previously. 5 Briefly, isolated cardiomyocytes were skinned in relaxing solution containing (in mmol/L) 10 EGTA, 5.9 MgAc, 5.9 Na 2 ATP, 10 creatine phosphate, 40 imidazole, 70 potassium proprionate, 5 NaN 3 , 0.5 PMSF, and 0.004 leupeptin; pH 7.0 with 1% Triton X-100. Cardiomyocytes were perfused using an eight-channel perfusion system that allowed quick switching and exclusive perfusion of a single cardiomyocyte with 8 different pCa (=-log [Ca 2+ ]) solutions. Sarcomere length was measured in each pCa solution using the IonOptix system. Cells were excluded from the study if sarcomere length in relaxing solution was <1.80 µm. Data were summarized from 10-12 cardiomyocytes from 4 mice in each group.
Human umbilical vein endothelial (HUVEC) cells were cultured in EGM growth medium (Lonza) containing EGM-2 supplement. Experiments were performed at passages 4-5. HUVEC cells were infected with adenoviral vector encoding wild-type PLN or mutant PLN (C36A/C41A/C46A) at 50 multiplicity of infection. Similarly, HUVEC cells were infected with adenoviral vector encoding wild-type cTnC or mutant cTnC (C35S/C84S) at 50 multiplicity of infection. After 36 h, cells were stimulated with 10µM ISO for 10 minutes. Cells were lysed in 500 µL lysis buffer (25mM Hepes (pH7.4), 50mM NaCl, 1mM EDTA, 0.2mM neocuproine, 1mM PMSF, 1%(v/v) NP-40 and protease inhibitor cocktail) and the biotin switch assay was then performed.
Measurement of sarcomere shortening and Ca
2+ transient in cultured cardiomyocytes 48 hours after infection with adenovirus, cover slips containing cardiomyocytes were transferred to S-(-)-Blebbistatin-free tyrode solution containing Fura2-AM 2 µmol/L and Pluronic F-175 0.04% (W/V). After S-(-)-Blebbistatin was washed out by perfusion for 20 min, cover slips were placed on the IonOptix microscope system as described above. Cultured cardiomyocytes were paced at 2 Hz and EGFP expression was confirmed using an FITC 485/505 nm exposure filter. Sarcomere length and Fura-2 fluorescence were recorded in EGFP-positive cardiomyocytes.
Statistics
All data are presented as mean ± standard error of the mean (s.e.m.), and the number of samples per group (N) is indicated for each experiment. For isolated cardiomyocyte experiments, measurements of all cells from one mouse were averaged and the average value for each mouse was used for statistical comparison between groups, unless otherwise specified. Data were analyzed using Prism 5 software package (GraphPad Software, La Jolla, CA). Statistical differences among groups were evaluated using the appropriate test as indicated in the text. P values smaller than 0.05 were considered significant. 
